Reaction Details Report a problem with these data
Target
Tyrosine-protein kinase JAK1 [850-1154]
Ligand
BDBM349041
Substrate
n/a
Meas. Tech.
JAK1 Inhibition Assay
IC50
550±n/a nM
Citation
Menet, CJ; Van Rompaey, LJ; Fletcher, SR; Blanc, J; Jouannigot, N; Hodges, AJ; Smits, KK Compounds useful for the treatment of degenerative and inflammatory diseases US Patent US10206907 Publication Date 2/19/2019
More Info.:
Target
Name:
Tyrosine-protein kinase JAK1 [850-1154]
Synonyms:
JAK1 | JAK1 (aa 850-1154) | JAK1A | JAK1B | JAK1_HUMAN
Type:
Enzyme Catalytic Domain
Mol. Mass.:
34949.64
Organism:
Homo sapiens (Human)
Description:
P23458[850-1154]
Residue:
305
Sequence:
EQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK
Inhibitor
Name:
BDBM349041
Synonyms:
N-(5-(4-((methyl(4-(pyridin-2- yl)benzyl)amino)methyl)phenyl)- [1,2,4]triazolo[1,5- a]pyridin-2- yl)cyclopropanecarboxamide | US10206907, Compound 159
Type:
Small organic molecule
Emp. Form.:
C30H28N6O
Mol. Mass.:
488.5829
SMILES:
CN(Cc1ccc(cc1)-c1ccccn1)Cc1ccc(cc1)-c1cccc2nc(NC(=O)C3CC3)nn12